WallStreetZenWallStreetZen

NASDAQ: SRRK
Scholar Rock Holding Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SRRK

Based on 5 analysts offering 12 month price targets for Scholar Rock Holding Corp.
Min Forecast
$20.00+44.4%
Avg Forecast
$25.60+84.84%
Max Forecast
$30.00+116.61%

Should I buy or sell SRRK stock?

Based on 5 analysts offering ratings for Scholar Rock Holding Corp.
Strong Buy
Strong Buy
4 analysts 80%
Buy
1 analysts 20%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SRRK stock forecasts and price targets.

SRRK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-03
lockedlocked$00.00+00.00%2024-03-28
lockedlocked$00.00+00.00%2024-03-26
lockedlocked$00.00+00.00%2024-03-19
lockedlocked$00.00+00.00%2023-10-25

1 of 1

Forecast return on equity

Is SRRK forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is SRRK forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

SRRK revenue forecast

What is SRRK's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$28.1M
Avg 2 year Forecast
$160.4M
Avg 3 year Forecast
$305.6M

SRRK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SRRK$13.85$25.60+84.84%Strong Buy
VIR$7.95$45.00+466.04%Buy
CNTA$10.57$11.33+7.22%Buy
TARS$32.44$48.00+47.97%Buy
MIRM$23.81$52.75+121.55%Strong Buy
View Top Biotech Stocks

Scholar Rock Holding Stock Forecast FAQ

Is Scholar Rock Holding Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: SRRK) stock is to Strong Buy SRRK stock.

Out of 5 analysts, 4 (80%) are recommending SRRK as a Strong Buy, 1 (20%) are recommending SRRK as a Buy, 0 (0%) are recommending SRRK as a Hold, 0 (0%) are recommending SRRK as a Sell, and 0 (0%) are recommending SRRK as a Strong Sell.

If you're new to stock investing, here's how to buy Scholar Rock Holding stock.

What is SRRK's revenue growth forecast for 2025-2027?

(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Scholar Rock Holding's revenue in 2024 is $0.On average, 6 Wall Street analysts forecast SRRK's revenue for 2025 to be $2,184,927,845, with the lowest SRRK revenue forecast at $217,246,924, and the highest SRRK revenue forecast at $6,852,232,728. On average, 7 Wall Street analysts forecast SRRK's revenue for 2026 to be $12,490,919,467, with the lowest SRRK revenue forecast at $3,753,154,744, and the highest SRRK revenue forecast at $22,114,023,804.

In 2027, SRRK is forecast to generate $23,797,959,997 in revenue, with the lowest revenue forecast at $6,478,474,579 and the highest revenue forecast at $37,107,176,211.

What is SRRK's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SRRK) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is SRRK's Price Target?

According to 5 Wall Street analysts that have issued a 1 year SRRK price target, the average SRRK price target is $25.60, with the highest SRRK stock price forecast at $30.00 and the lowest SRRK stock price forecast at $20.00.

On average, Wall Street analysts predict that Scholar Rock Holding's share price could reach $25.60 by Apr 3, 2025. The average Scholar Rock Holding stock price prediction forecasts a potential upside of 84.84% from the current SRRK share price of $13.85.

What is SRRK's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SRRK) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.